Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 12 | 2024 | 90 | 4.420 |
Why?
|
| Contraception | 8 | 2023 | 60 | 2.820 |
Why?
|
| Telemedicine | 4 | 2023 | 215 | 1.420 |
Why?
|
| Pregnancy | 18 | 2024 | 1737 | 1.400 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2019 | 172 | 1.040 |
Why?
|
| Intrauterine Devices | 3 | 2021 | 19 | 0.960 |
Why?
|
| Metrorrhagia | 1 | 2025 | 8 | 0.930 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2025 | 14 | 0.920 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 28 | 0.810 |
Why?
|
| Condoms | 2 | 2019 | 148 | 0.700 |
Why?
|
| Mifepristone | 5 | 2025 | 34 | 0.670 |
Why?
|
| Female | 22 | 2025 | 24018 | 0.620 |
Why?
|
| Insurance Coverage | 1 | 2020 | 108 | 0.620 |
Why?
|
| Contraception Behavior | 1 | 2019 | 33 | 0.610 |
Why?
|
| Social Behavior | 1 | 2020 | 160 | 0.610 |
Why?
|
| Physicians | 1 | 2020 | 180 | 0.580 |
Why?
|
| Directive Counseling | 1 | 2017 | 16 | 0.550 |
Why?
|
| Reproductive Health Services | 1 | 2015 | 14 | 0.480 |
Why?
|
| Adolescent Health Services | 1 | 2015 | 29 | 0.480 |
Why?
|
| Pregnancy in Adolescence | 1 | 2015 | 34 | 0.470 |
Why?
|
| Humans | 22 | 2025 | 42163 | 0.460 |
Why?
|
| Heart Arrest | 2 | 2024 | 52 | 0.430 |
Why?
|
| Hawaii | 6 | 2024 | 2004 | 0.430 |
Why?
|
| United States | 6 | 2023 | 5072 | 0.340 |
Why?
|
| Pregnancy, Unplanned | 2 | 2021 | 29 | 0.310 |
Why?
|
| Adolescent | 6 | 2021 | 5950 | 0.300 |
Why?
|
| Misoprostol | 3 | 2022 | 27 | 0.260 |
Why?
|
| Adult | 7 | 2024 | 13458 | 0.260 |
Why?
|
| Counseling | 2 | 2023 | 134 | 0.240 |
Why?
|
| Tranexamic Acid | 1 | 2025 | 3 | 0.230 |
Why?
|
| Doxycycline | 1 | 2025 | 32 | 0.230 |
Why?
|
| Tamoxifen | 1 | 2025 | 67 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2025 | 147 | 0.210 |
Why?
|
| Gender Identity | 1 | 2024 | 117 | 0.200 |
Why?
|
| Family Planning Services | 1 | 2023 | 34 | 0.200 |
Why?
|
| Needs Assessment | 1 | 2024 | 180 | 0.190 |
Why?
|
| Pregnancy, Unwanted | 1 | 2021 | 10 | 0.180 |
Why?
|
| Contraceptive Agents | 1 | 2021 | 13 | 0.180 |
Why?
|
| Analgesics | 1 | 2022 | 55 | 0.180 |
Why?
|
| Abortion, Legal | 1 | 2021 | 6 | 0.180 |
Why?
|
| Abortifacient Agents, Steroidal | 1 | 2021 | 3 | 0.180 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2021 | 10 | 0.180 |
Why?
|
| Postal Service | 1 | 2021 | 12 | 0.180 |
Why?
|
| Abortifacient Agents | 1 | 2021 | 11 | 0.170 |
Why?
|
| Guam | 1 | 2021 | 83 | 0.170 |
Why?
|
| Young Adult | 3 | 2021 | 4936 | 0.170 |
Why?
|
| Gestational Age | 1 | 2020 | 195 | 0.150 |
Why?
|
| Male | 5 | 2024 | 22779 | 0.150 |
Why?
|
| Pain | 1 | 2022 | 283 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 138 | 0.140 |
Why?
|
| Privacy | 1 | 2017 | 7 | 0.140 |
Why?
|
| Drug Implants | 1 | 2017 | 20 | 0.140 |
Why?
|
| Confidentiality | 1 | 2017 | 27 | 0.140 |
Why?
|
| Contraceptive Agents, Female | 1 | 2017 | 25 | 0.130 |
Why?
|
| Decision Making | 1 | 2019 | 242 | 0.130 |
Why?
|
| Retrospective Studies | 2 | 2021 | 2485 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2019 | 526 | 0.130 |
Why?
|
| Sexual Partners | 1 | 2019 | 325 | 0.120 |
Why?
|
| Hemoperitoneum | 1 | 2015 | 1 | 0.120 |
Why?
|
| Wandering Spleen | 1 | 2015 | 1 | 0.120 |
Why?
|
| Abdominal Abscess | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3077 | 0.120 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2015 | 19 | 0.120 |
Why?
|
| Prevalence | 1 | 2020 | 1597 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2020 | 634 | 0.110 |
Why?
|
| Digoxin | 2 | 2024 | 10 | 0.110 |
Why?
|
| Lidocaine | 2 | 2024 | 16 | 0.110 |
Why?
|
| Sex Education | 1 | 2013 | 36 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 270 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2013 | 141 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 222 | 0.090 |
Why?
|
| Schools | 1 | 2013 | 283 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 680 | 0.080 |
Why?
|
| Middle Aged | 2 | 2021 | 11819 | 0.070 |
Why?
|
| Students | 1 | 2013 | 617 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 959 | 0.060 |
Why?
|
| Fetal Viability | 1 | 2024 | 6 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2023 | 143 | 0.050 |
Why?
|
| Gynecology | 1 | 2022 | 33 | 0.050 |
Why?
|
| Hormones | 1 | 2022 | 56 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 7 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2022 | 34 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2022 | 28 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 22 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 40 | 0.040 |
Why?
|
| HIV Infections | 1 | 2015 | 2535 | 0.040 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2020 | 12 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 245 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 362 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 2015 | 1 | 0.030 |
Why?
|
| Rupture | 1 | 2015 | 5 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 17 | 0.030 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2013 | 17 | 0.030 |
Why?
|
| Cities | 1 | 2013 | 78 | 0.030 |
Why?
|
| Safe Sex | 1 | 2013 | 78 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2013 | 211 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1574 | 0.020 |
Why?
|